BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26009469)

  • 1. Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.
    Foight GW; Keating AE
    J Mol Biol; 2015 Jul; 427(15):2468-2490. PubMed ID: 26009469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak.
    Cheng EH; Nicholas J; Bellows DS; Hayward GS; Guo HG; Reitz MS; Hardwick JM
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):690-4. PubMed ID: 9012846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.
    Dutta S; Gullá S; Chen TS; Fire E; Grant RA; Keating AE
    J Mol Biol; 2010 May; 398(5):747-62. PubMed ID: 20363230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
    Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
    Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting γ-herpesvirus 68 Bcl-2-mediated down-regulation of autophagy.
    Su M; Mei Y; Sanishvili R; Levine B; Colbert CL; Sinha S
    J Biol Chem; 2014 Mar; 289(12):8029-40. PubMed ID: 24443581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
    Modi V; Sankararamakrishnan R
    J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2.
    Flanagan AM; Letai A
    Cell Death Differ; 2008 Mar; 15(3):580-8. PubMed ID: 18084238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
    Zhang S; Long A; Link AJ
    ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2.
    London N; Gullá S; Keating AE; Schueler-Furman O
    Biochemistry; 2012 Jul; 51(29):5841-50. PubMed ID: 22702834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.
    Chen L; Willis SN; Wei A; Smith BJ; Fletcher JI; Hinds MG; Colman PM; Day CL; Adams JM; Huang DC
    Mol Cell; 2005 Feb; 17(3):393-403. PubMed ID: 15694340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor.
    Harvey EP; Seo HS; Guerra RM; Bird GH; Dhe-Paganon S; Walensky LD
    Structure; 2018 Jan; 26(1):153-160.e4. PubMed ID: 29276033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL.
    Dutta S; Ryan J; Chen TS; Kougentakis C; Letai A; Keating AE
    J Mol Biol; 2015 Mar; 427(6 Pt B):1241-1253. PubMed ID: 25451027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide prediction and validation of peptides that bind human prosurvival Bcl-2 proteins.
    DeBartolo J; Taipale M; Keating AE
    PLoS Comput Biol; 2014 Jun; 10(6):e1003693. PubMed ID: 24967846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
    Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
    Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2.
    Huang Q; Petros AM; Virgin HW; Fesik SW; Olejniczak ET
    J Mol Biol; 2003 Oct; 332(5):1123-30. PubMed ID: 14499614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural biology of the Bcl-2 family of proteins.
    Petros AM; Olejniczak ET; Fesik SW
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells.
    Foight GW; Ryan JA; Gullá SV; Letai A; Keating AE
    ACS Chem Biol; 2014 Sep; 9(9):1962-8. PubMed ID: 25052212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.